Compact adenine base editors to enable therapeutic rescue of Duchenne muscular dystrophy
Rallapalli, K. L.; Ho, J.; Nocedal, I.; Tan, J. W.; Ocampo, R. F.; Thomas, N. C.; Justice, B.; Jirde, S.; Gonzalez-Osorio, L.; Castelle, C. J.; Lin, J.-L.; Wright, J. T.; Toch, S.; Shah, K.; Freeman, B.; Rehman, J.; Muysson, J.; Krudop, I.; Alexander, L. M.; Brooks, A. R.; Brown, C. T.; Goltsman, D. S. A.; Hoff, K. G.; Szymanski, P.; Thomas, B. C.; Taylor, D. W.; Butterfield, C. N.
Show abstract
Adenine base editors (ABEs) have emerged as a powerful gene-editing technology enabling precise and programmable adenine-to-guanine substitutions across the genome. However, their translation into in vivo therapeutics is limited by delivery challenges, as their size exceeds the packaging capacity of adeno-associated virus (AAV). Here, we report the discovery, structural characterization, and engineering of two compact, highly active ABEs built on novel deaminases and Cas9d nucleases, enabling all-in-one, single-vector AAV delivery. Applying these compact ABEs to Duchenne muscular dystrophy (DMD), we demonstrate efficient disruption of conserved splice-acceptor sites at dystrophin exons 45 and 51 in human skeletal muscle cells, enabling therapeutically relevant exon skipping. Together, these ABEs help expand the therapeutic reach of base editing towards diverse tissue types and disease targets.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting base editing outcomes with an attention-based deep learning algorithm trained on high-throughput target library screens 95%
- Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase 95%
- Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2 94%
Similar papers in this journal
Similar papers in this journal
- Directed Evolution of Adenine Base Editors with Increased Activity and Therapeutic Application 95%
- Model-directed generation of CRISPR-Cas13a guide RNAs designs artificial sequences that improve nucleic acid detection 95%
- Pythia: Non-random DNA repair allows predictable CRISPR/Cas9 integration and gene editing 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.